1-3 of 3
Michal Dranitzki-Elhalel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CTLA4-FasL, the Hexameric Targeted FasL Fusion Protein, As Potential Novel Treatment for DLBCL

Alexandra Aronin, PhD, Liat Ben Gigi-Tamir, PhD, Efi Makdasi, PhD, Shira Amsili, PhD, Shlomi Ben David, Ortal Avraham, Yehudith Jitka Sagiv, Yosi Meir Gozlan, PhD, Noam Shani, PhD, Michal Dranitzki Elhalel, MD MSc
Journal: Blood
Blood (2017) 130 (Supplement 1): 4107.
https://doi.org/10.1182/blood.V130.Suppl_1.4107.4107
Published: 2017
Journal Articles

Targeting Lymphoma By the Bi-Functional Hexameric Fusion Protein CTLA4-Fasl; Mode-of-Action, Pre-Clinical Efficacy and Toxicology Studies

Alexandra Aronin, Shira Amsili, Tatyana Prigozhina, Moshe Baru, Efi Makdasi, Kobi Tzdaka, Fanny Shkedy, Noam Shani, Michal Dranitzki Elhalel
Journal: Blood
Blood (2015) 126 (23): 1553.
https://doi.org/10.1182/blood.V126.23.1553.1553
Published: 2015
Journal Articles

Human erythropoietin gene therapy for patients with chronic renal failure

Yitzhak Lippin, Michal Dranitzki-Elhalel, Einat Brill-Almon, Chava Mei-Zahav, Sarah Mizrachi, Yael Liberman, Adrian Iaina, Eli Kaplan, Eduardo Podjarny, Evelyne Zeira, Menahem Harati, Nicole Casadevall, Noam Shani, Eithan Galun
Journal: Blood
Blood (2005) 106 (7): 2280–2286.
https://doi.org/10.1182/blood-2004-11-4174
Published: 2005